stocktin

check moneycontrol mmb for detailed view

[stocktin @stocktin]

@biosimilarz Wonder how much they shall get for this & cd tht become a benchmark for valuing comps with phase3 biosim assets #pfe #inflixim

[stocktin @stocktin]

@thejosh111 @biosimilarz Wonder how much they shall get for this & cd tht become a benchmark for valuing comps with phase3 biosim assets

[stocktin @stocktin]

@biosimilarz Wonder if we are getting any closer to finding out the identity of the rh insulin filler with the ema

[stocktin @stocktin]

@jimbo_the_1st sorry missed ur tweet : meant the company which has filled its rh insulin with ema for approval

[stocktin @stocktin]

@biosimilarz wonder when we shall hv the rh insulin filler out in the open BTW any update

[stocktin @stocktin]

@biosimilarz thks

[stocktin @stocktin]

@biosimilarz Wonder if u hv any update on the rh Insulin filler with the EMA now?

[stocktin @stocktin]

@biosimilarz #biocon qtrly concall : expect 3 more biosim to be in phase 3 by next yr. This then becomes a rekonable portfolio 5 biosim +rh

[stocktin @stocktin]

@biosimilarz just a long shot :cd it be tht in their previous submission the EMA found only process concerns which they hv since addressed

[stocktin @stocktin]

@ankurjain1978 @biosimilarz thks for the info wasnt aware

[stocktin @stocktin]

@biosimilarz If it is true it is even more surprising I believe u still hv to do trials to submit to EMA which marvel hasnt done

[stocktin @stocktin]

@biosimilarz if for nothing else Marvel deserves 5 stars for persistence

[stocktin @stocktin]

@biosimilarz & now sir u hv got me(& pl dont look around for your father)

[stocktin @stocktin]

@biosimilarz well at least the current programs Teva thinks of them as assets the long term vision might evolve later

[stocktin @stocktin]

@biosimilarz agree In the press release Teva talks abt Myls 'Wave2 biosimilars' maybe thts a hint for things to come.

[stocktin @stocktin]

@biosimilarz how wd u rate this development for @Bioconlimited Better prospects for its biosim aspirations Teva is rather aggressive

[stocktin @stocktin]

@biosimilarz @ankurjain1978 this cd really annoy Cofepris since Biocon says approved under guidelines set in 2012 for biocomparability

[stocktin @stocktin]

@biosimilarz here http://t.co/6iWH0xdID2 & abt the awesome bit think every body is taking a cue from u

[stocktin @stocktin]

@biosimilarz thanks so much but let me start the news sharing.Their Glargine gets approved in Mexico

[stocktin @stocktin]

@biosimilarz I look at ur handle everyday religiously to spot biocon/mylan trial updates .Alas non forthcoming!